News | August 31, 2023
Lupin launches propranolol capsules to improve heart health in Canada
Propranolol LA is a generic equivalent of Inderal LA
Propranolol LA is a generic equivalent of Inderal LA
Novo Nordisk’s GLP-1 Ozempic has reported a YoY increase in revenue from $2.1 billion to $3.2 billion
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
This product will be manufactured at Lupin's Pithampur facility in India
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Eris Lifesciences enters into term loan agreement with Citi Bank
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Subscribe To Our Newsletter & Stay Updated
